Related Experiment Videos
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic
C Van Den Berg1, X Y Guan, D Von Hoff
1University of Texas Health Science Center, San Antonio, Texas 78284, USA.
Summary
Gene amplification at 8q24 is significant in prostate cancer progression. This genetic change, identified using multiple methods, may serve as a diagnostic marker for advanced disease.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Gene amplification, an increase in DNA sequence copy number, plays a role in human cancers.
- Understanding specific genetic alterations in prostate cancer is crucial for diagnosis and prognosis.
Purpose of the Study:
- To investigate the significance of gene amplification in human prostate cancers.
- To identify common amplified DNA regions in prostate cancer cells.
- To determine the prevalence of these genetic changes in primary and recurrent prostate tumors.
Main Methods:
- Chromosome microdissection to identify amplified DNA regions.
- Comparative genomic hybridization (CGH) for genome-wide copy number analysis.
- Fluorescence in situ hybridization (FISH) to validate and quantify gene amplification in patient samples.
Main Results:
- Chromosome microdissection identified a common amplified region at 8q24.1-24.2.
- FISH analysis revealed 8q24 amplification in 9% of primary prostate tumors.
- CGH and FISH showed 8q24 gain in 89% of recurrent prostate cancer cases.
Conclusions:
- Increased DNA sequence copy number at 8q24 is prevalent in prostate cancer, particularly in recurrent disease.
- The 8q24 amplification may be associated with prostate cancer progression.
- Analysis of 8q24 gain could offer diagnostic utility as a marker for prostate cancer progression.